MedPath

Affectis Pharmaceuticals AG

Affectis Pharmaceuticals AG logo
🇩🇪Germany
Ownership
Subsidiary
Established
2002-01-01
Employees
11
Market Cap
-
Website
http://www.affectis.com

Clinical Trials

4

Active:3
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Cimicoxib for the Treatment of Major Depression (SECIM)

Phase 2
Completed
Conditions
Major Depression
Interventions
Drug: Placebo
First Posted Date
2007-08-02
Last Posted Date
2013-11-13
Lead Sponsor
Affectis Pharmaceuticals AG
Target Recruit Count
169
Registration Number
NCT00510822
Locations
🇦🇹

Landeskrankenhaus Klagenfurt, Abteilung für Psychiatrie und Psychotherapie, Klagenfurt, Austria

🇦🇹

Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg, Austria

🇨🇿

Faculty Hospital Brno, Brno, Czech Republic

and more 22 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.